These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28642038)

  • 1. Functional characterization of 21 allelic variants of dihydropyrimidinase.
    Hishinuma E; Akai F; Narita Y; Maekawa M; Yamaguchi H; Mano N; Oda A; Hirasawa N; Hiratsuka M
    Biochem Pharmacol; 2017 Nov; 143():118-128. PubMed ID: 28642038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Characterization of 12 Dihydropyrimidinase Allelic Variants in Japanese Individuals for the Prediction of 5-Fluorouracil Treatment-Related Toxicity.
    Hishinuma E; Narita Y; Rico EMG; Ueda A; Obuchi K; Tanaka Y; Saito S; Tadaka S; Kinoshita K; Maekawa M; Mano N; Nakayoshi T; Oda A; Hirasawa N; Hiratsuka M
    Drug Metab Dispos; 2023 Feb; 51(2):165-173. PubMed ID: 36414408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Characterization of 21 Allelic Variants of Dihydropyrimidine Dehydrogenase Identified in 1070 Japanese Individuals.
    Hishinuma E; Narita Y; Saito S; Maekawa M; Akai F; Nakanishi Y; Yasuda J; Nagasaki M; Yamamoto M; Yamaguchi H; Mano N; Hirasawa N; Hiratsuka M
    Drug Metab Dispos; 2018 Aug; 46(8):1083-1090. PubMed ID: 29769267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydropyrimidinase deficiency in four East Asian patients due to novel and rare DPYS mutations affecting protein structural integrity and catalytic activity.
    Nakajima Y; Meijer J; Dobritzsch D; Ito T; Zhang C; Wang X; Watanabe Y; Tashiro K; Meinsma R; Roelofsen J; Zoetekouw L; van Kuilenburg ABP
    Mol Genet Metab; 2017 Dec; 122(4):216-222. PubMed ID: 29054612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of dihydropyrimidinase in a Japanese patient with capecitabine-induced toxicity.
    Hiratsuka M; Yamashita H; Akai F; Hosono H; Hishinuma E; Hirasawa N; Mori T
    PLoS One; 2015; 10(4):e0124818. PubMed ID: 25915935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism.
    Thomas HR; Ezzeldin HH; Guarcello V; Mattison LK; Fridley BL; Diasio RB
    Pharmacogenet Genomics; 2007 Nov; 17(11):973-87. PubMed ID: 18075467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropyrimidinase deficiency: Phenotype, genotype and structural consequences in 17 patients.
    van Kuilenburg AB; Dobritzsch D; Meijer J; Meinsma R; Benoist JF; Assmann B; Schubert S; Hoffmann GF; Duran M; de Vries MC; Kurlemann G; Eyskens FJ; Greed L; Sass JO; Schwab KO; Sewell AC; Walter J; Hahn A; Zoetekouw L; Ribes A; Lind S; Hennekam RC
    Biochim Biophys Acta; 2010; 1802(7-8):639-48. PubMed ID: 20362666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Pre-mRNA Splicing Caused by a Novel Intronic Mutation c.1443+5G>A in the Dihydropyrimidinase (DPYS) Gene.
    Nakajima Y; Meijer J; Zhang C; Wang X; Kondo T; Ito T; Dobritzsch D; Van Kuilenburg AB
    Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26771602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of dihydropyrimidinase gene alterations to the development of serious toxicity in fluoropyrimidine-treated cancer patients.
    Fidlerova J; Kleiblova P; Bilek M; Kormunda S; Formankova Z; Novotny J; Kleibl Z
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):661-9. PubMed ID: 19649633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism.
    Thomas HR; Ezzeldin HH; Guarcello V; Mattison LK; Fridley BL; Diasio RB
    Pharmacogenet Genomics; 2008 Jan; 18(1):25-35. PubMed ID: 18216719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of 40 CYP2B6 allelic variants by assessing efavirenz 8-hydroxylation.
    Watanabe T; Saito T; Rico EMG; Hishinuma E; Kumondai M; Maekawa M; Oda A; Saigusa D; Saito S; Yasuda J; Nagasaki M; Minegishi N; Yamamoto M; Yamaguchi H; Mano N; Hirasawa N; Hiratsuka M
    Biochem Pharmacol; 2018 Oct; 156():420-430. PubMed ID: 30201214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, biochemical and genetic findings in two siblings with a dihydropyrimidinase deficiency.
    van Kuilenburg AB; Meijer J; Dobritzsch D; Meinsma R; Duran M; Lohkamp B; Zoetekouw L; Abeling NG; van Tinteren HL; Bosch AM
    Mol Genet Metab; 2007 Jun; 91(2):157-64. PubMed ID: 17383919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural investigation of pathogenic variants in dihydropyrimidinase using molecular dynamics simulations.
    Kato K; Nakayoshi T; Nagura A; Hishinuma E; Hiratsuka M; Kurimoto E; Oda A
    J Mol Graph Model; 2022 Dec; 117():108288. PubMed ID: 35961217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common dihydropyrimidinase ( DPYS ) genetic variations do not predict fluoropyrimidine-related chemotherapy toxicity in a Canadian cohort.
    Medwid SJ; Mailloux JL; Wigle TJ; Kim RB
    Pharmacogenet Genomics; 2024 Apr; 34(3):83-87. PubMed ID: 38215018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyrimidinase and β-ureidopropionase gene variation and severe fluoropyrimidine-related toxicity.
    Kummer D; Froehlich TK; Joerger M; Aebi S; Sistonen J; Amstutz U; Largiadèr CR
    Pharmacogenomics; 2015; 16(12):1367-77. PubMed ID: 26244261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of rare variants in DPYS gene is a novel predictor of the risk of developing severe fluoropyrimidine-related toxicity.
    De Mattia E; Polesel J; Silvestri M; Roncato R; Scarabel L; Calza S; Spina M; Puglisi F; Toffoli G; Cecchin E
    Hum Genomics; 2023 Nov; 17(1):99. PubMed ID: 37946254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of Rare
    Hishinuma E; Narita Y; Obuchi K; Ueda A; Saito S; Tadaka S; Kinoshita K; Maekawa M; Mano N; Hirasawa N; Hiratsuka M
    Front Pharmacol; 2022; 13():930470. PubMed ID: 35784703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogenetic analysis and biochemical characterization of a thermostable dihydropyrimidinase from alkaliphilic Bacillus sp. TS-23.
    Lin LL; Hsu WH; Hsu WY; Kan SC; Hu HY
    Antonie Van Leeuwenhoek; 2005; 88(3-4):189-97. PubMed ID: 16284925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydropyrimidinase deficiency: the first feline case of dihydropyrimidinuria with clinical and molecular findings.
    Chang HS; Shibata T; Arai S; Zhang C; Yabuki A; Mitani S; Higo T; Sunagawa K; Mizukami K; Yamato O
    JIMD Rep; 2012; 6():21-6. PubMed ID: 23430934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymes of uracil catabolism in normal and neoplastic human tissues.
    Naguib FN; el Kouni MH; Cha S
    Cancer Res; 1985 Nov; 45(11 Pt 1):5405-12. PubMed ID: 3931905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.